Assistive ExoSkeleton and ExoTendon System for Increased Return of Limb Function after Diabetic Foot Ulcer
Award amount
$1,689,551Program and phase
SBIR · Phase II – Direct to Phase IIAward year
2021Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- RESULTS GROUP, LLC
- Proposal award date
- 2021-05-17
- Contract end date
- 2023-04-30
- UEI
- KR49VQHNMHD1
- Solicitation number
- PA20-262
- Topic code
- 600
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Modernizing canine paw protection through advanced multi-domain fiber materials and computerized knitting technology
- Multi-Mode Exoskeleton Boot to Facilitate Rehabilitation and Return to Service
- Expanding Access to Assistive Walking Devices: Managing Symptoms for Child and Adolescent CMT Patients with Exoskeletal Boots.
- Reimagining Mobility for Adolescents with CMT User-Centric Development of Exoskeletons as Next-Gen Alternatives to Traditional AFOs
- Assistive ExoSkeleton & ExoTendon Platform to Enable Wearable Rehabilitation Robotics
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Integrating AI nowcasting models with digital communications to reduce RSV infections in rural areas
- An Innovative, Interactive, Model-Driven Serious Game for Health Literacy Engagement and Education
- Q-rounds: Making Multi-Disciplinary Family Centered Rounds and Achievable Standard of Care through Novel Virtual Rounding Features
- Refinement of a Digital Monitoring System to Reduce Risk of Hospital Acquired Pressure Injuries
- Development of an accessible Cognitive Behavioral Therapy digital therapeutic for individuals with Long COVID
Research funding history
11 SBIR/STTR records share this UEI (2008–2025). Reported award amounts total $5,605,057. Reported amounts are not federal obligations.
Phases: Phase I, Phase II – Direct to Phase II, Phase II
Agencies: Department of Health and Human Services, Department of Defense